MedPath

Effect of Guduchighan Vati in Vatarakta ( Hyperuricemia)

Phase 1
Conditions
Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
Registration Number
CTRI/2020/06/026079
Lead Sponsor
College Principal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient of either sex in the age group between 20-70 years.

2.Patient having serum uric acid level more then 7mg/dl(male) and 6mg/dl(female) with or without any associated features of joint inflammation.

3.Willing to participate and able to provide signed informed consent.

Exclusion Criteria

1.Patient not willing for the trial.

2.Patient below age of 20 years and above 70 years of age.

3.Patient suffering from any other form of Arthritis like R.A, O.A, Tubercular Arthritis, Rheumatoid Arthritis etc.

4.Patient suffering from chronic renal, respiratory, cardiac and hepatic disorders.

5.Patient having malignant disorders.

6. Patient who has completed participation in any other clinical trial during the past 3 months.

7.Any condition which the investigator thinks may compromise with the safety of the object.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fulfillment of subjective and objective criteriaTimepoint: 6 Weeks
Secondary Outcome Measures
NameTimeMethod
General feeling of well beingTimepoint: 6 weeks
© Copyright 2025. All Rights Reserved by MedPath